Taken together, an altered MAP3K8 signaling worsens pulmonary fibrosis via a COX-2-dependent metabolic mechanism, highlighting a potential protective role for MAP3K8 in IPF [99]. The gene discussed is MAP3K8; the disease is idiopathic pulmonary fibrosis.